Allan Shaw - Net Worth and Insider Trading

Allan Shaw Net Worth

The estimated net worth of Allan Shaw is at least $0 dollars as of 2024-11-06. Allan Shaw is the Director of Onconetix Inc and owns about 0 shares of Onconetix Inc (ONCO) stock worth over $0. Details can be seen in Allan Shaw's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Allan Shaw has not made any transactions after 2022-08-19 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Allan Shaw

Allan Shaw Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Allan Shaw owns 5 companies in total, including VIVUS Inc (VVUSQ) , Syndax Pharmaceuticals Inc (SNDX) , and Akari Therapeutics PLC (AKTX) among others .

Click here to see the complete history of Allan Shaw’s form 4 insider trades.

Insider Ownership Summary of Allan Shaw

Ticker	Comapny	Transaction Date	Type of Owner
VVUSQ	VIVUS Inc	2018-10-26	director
SNDX	Syndax Pharmaceuticals Inc	2016-03-02	Chief Financial Officer
AKTX	Akari Therapeutics PLC	2015-01-01	director
		2022-08-19	director
		2023-03-20	director

Allan Shaw Latest Holdings Summary

Allan Shaw currently owns a total of 1 stock. Allan Shaw owns 0 shares of Onconetix Inc (ONCO) as of August 19, 2022, with a value of $0.

Latest Holdings of Allan Shaw

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
ONCO	Onconetix Inc	2022-08-19	0	2.83	0

Holding Weightings of Allan Shaw

Allan Shaw Form 4 Trading Tracker

According to the SEC Form 4 filings, Allan Shaw has made a total of 1 transactions in Onconetix Inc (ONCO) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Onconetix Inc is the sale of 741 shares on August 19, 2022, which brought Allan Shaw around $116,766.

Insider Trading History of Allan Shaw

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Allan Shaw Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Allan Shaw Ownership Network

Ownership Network List of Allan Shaw

No Data

Ownership Network Relation of Allan Shaw

Allan Shaw Owned Company Details

What does VIVUS Inc do?

Who are the key executives at VIVUS Inc?

Allan Shaw is the director of VIVUS Inc. Other key executives at VIVUS Inc include director & Chief Executive Officer John P. Amos , Chief Medical Officer Santosh T Varghese , and Chief Financial Officer & CAO Mark K Oki .

VIVUS Inc (VVUSQ) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of VIVUS Inc (VVUSQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of VIVUS Inc (VVUSQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

VIVUS Inc (VVUSQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

VIVUS Inc Insider Transactions

No Available Data

What does Syndax Pharmaceuticals Inc do?

Who are the key executives at Syndax Pharmaceuticals Inc?

Allan Shaw is the Chief Financial Officer of Syndax Pharmaceuticals Inc. Other key executives at Syndax Pharmaceuticals Inc include Chief Financial Officer Keith A. Goldan , director & Chief Executive Officer Briggs Morrison , and President & Head of R&D Neil Gallagher .

Syndax Pharmaceuticals Inc (SNDX) Insider Trades Summary

Over the past 18 months, Allan Shaw made no insider transaction in Syndax Pharmaceuticals Inc (SNDX). Other recent insider transactions involving Syndax Pharmaceuticals Inc (SNDX) include a net sale of 211,420 shares made by Briggs Morrison , a net purchase of 673 shares made by Keith A. Goldan , and a net sale of 83,000 shares made by William Meury .

In summary, during the past 3 months, insiders sold 0 shares of Syndax Pharmaceuticals Inc (SNDX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 294,997 shares of Syndax Pharmaceuticals Inc (SNDX) were sold and 1,250 shares were bought by its insiders, resulting in a net sale of 293,747 shares.

Syndax Pharmaceuticals Inc (SNDX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Syndax Pharmaceuticals Inc Insider Transactions

No Available Data

What does Akari Therapeutics PLC do?

Who are the key executives at Akari Therapeutics PLC?

Allan Shaw is the director of Akari Therapeutics PLC. Other key executives at Akari Therapeutics PLC include General Counsel and Secretary Robert M Shaw , director & 10 percent owner James Hill , and director & 10 percent owner Stuart Ungar .

Akari Therapeutics PLC (AKTX) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Akari Therapeutics PLC (AKTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Akari Therapeutics PLC (AKTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Akari Therapeutics PLC (AKTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Akari Therapeutics PLC Insider Transactions

No Available Data

What does Onconetix Inc do?

Who are the key executives at Onconetix Inc?

Allan Shaw is the director of Onconetix Inc. Other key executives at Onconetix Inc include director & Chief Executive Officer Neil J Campbell , Chief Financial Officer Bruce Harmon , and 10 percent owner Cincinnati Cornerstone Investors Bwv I, Llc .

Onconetix Inc (ONCO) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Onconetix Inc (ONCO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Onconetix Inc (ONCO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Onconetix Inc (ONCO)'s detailed insider trading history can be found in Insider Trading Tracker table.

Onconetix Inc Insider Transactions

No Available Data

What does CalciMedica Inc do?

Who are the key executives at CalciMedica Inc?

Allan Shaw is the director of CalciMedica Inc. Other key executives at CalciMedica Inc include director & 10 percent owner & Chief Business Officer Eric W Roberts , 10 percent owner Sanderling Venture Partners Vi Co Investment Fund Lp , and director & 10 percent owner Fred A Middleton .

CalciMedica Inc (CALC) Insider Trades Summary

Over the past 18 months, Allan Shaw made no insider transaction in CalciMedica Inc (CALC). Other recent insider transactions involving CalciMedica Inc (CALC) include a net purchase of 133,737 shares made by Eric W Roberts , a net purchase of 41,768 shares made by A. Rachel Leheny , and a net purchase of 798,842 shares made by Fred A Middleton .

In summary, during the past 3 months, insiders sold 0 shares of CalciMedica Inc (CALC) in total and bought 387,154 shares, with a net purchase of 387,154 shares. During the past 18 months, 0 shares of CalciMedica Inc (CALC) were sold and 1,957,290 shares were bought by its insiders, resulting in a net purchase of 1,957,290 shares.

CalciMedica Inc (CALC)'s detailed insider trading history can be found in Insider Trading Tracker table.

CalciMedica Inc Insider Transactions

No Available Data

Allan Shaw Mailing Address

Above is the net worth, insider trading, and ownership report for Allan Shaw. You might contact Allan Shaw via mailing address: C/o Celsus Therapeutics Plc, 24 West 40th Street, New York Ny 10018.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.